Overview of Dr. Stadler
Dr. Walter Stadler is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Yale School of Medicine and has been in practice 29 years. Dr. Stadler accepts several types of health insurance, listed below. He is one of 123 doctors at University of Chicago Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
5841 S. MARYLAND AVE.
M/C 2115
Chicago, IL 60637Fax+1 773-702-3163- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1991 - 1994
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1988 - 1991
- Yale School of MedicineClass of 1988
Certifications & Licensure
- IL State Medical License 1988 - 2026
- IN State Medical License 2023 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly
- Chicago Magazine: Top Doctors Castle Connolly
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Oxaliplatin in Treating Patients With Metastatic Bladder Cancer Start of enrollment: 2000 Feb 01
- O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma Start of enrollment: 2000 Jun 01
- Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer Start of enrollment: 1999 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Optimizing the doses of cancer drugs after usual dose finding.Strohbehn, G., Boonstra, P., Stadler, W., Ratain, M.> ;Clinical Trials. 2023 Dec 27
- PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.Channing J Paller, Pedro C Barata, Justin Lorentz, Leonard J Appleman, Andrew J Armstrong, Tiffani A DeMarco, Robert Dreicer, Jo Ann B Elrod, Mark Fleming, Christopher...> ;The Prostate. 2024 Feb 1
- 1 citationsA multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.A J Rosenberg, C-Y Liao, T Karrison, J A de Souza, F P Worden, B Libao, M K Krzyzanowska, D N Hayes, E Winquist, V Saloura, K Prescott, V M Villaflor, T Y Seiwert, R B...> ;Annals of Oncology. 2023 Aug 1
- Join now to see all
Journal Articles
- Publisher Correction: Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell Ca...Michael B Atkins, Mario Sznol, Robert J Motzer, Richard W Joseph, Thomas Hutson, John Hainsworth, W Kimryn Rathmell, Brian I Rini, David F McDermott, Toni K Choueiri, ..., Nature
- Clinical Activity and Molecular Correlates of Response to Atezolizumab Alone or in Combination with Bevacizumab Versus Sunitinib in Renal Cell CarcinomaMichael B Atkins, Thomas Hutson, Mario Sznol, Toni K Choueiri, Sumanta K Pal, Richard W Joseph, John Hainsworth, W Kimryn Rathmell, David F McDermott, Robert J Motzer,..., Nature
Authored Content
- Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic CancersJanuary 2018
Press Mentions
- The Caris Precision Oncology Alliance Welcomes University of Chicago Medicine Comprehensive Cancer CenterMarch 8th, 2023
- Stand up to Cancer Announces Four Teams Focused on Diversity in Early Phase Cancer Clinical TrialsFebruary 8th, 2023
- Myovant’s Phase III Relugolix Trial’s Cardiovascular Event Reduction Trend InconclusiveJune 18th, 2020
- Join now to see all
Grant Support
- Protocol Review And Monitoring SystemNational Cancer Institute2008–2012
- Dynamic-Contrast Enhanced MRI As A BAY 43-9006 MarkerNational Cancer Institute2005–2006
- Biomarkers For Bladder Cancer Chemoprevention TrialsNational Cancer Institute1998–1999
Professional Memberships
- Member
- Fellow
- Member
- Member
Hospital Affiliations
- University of Chicago Medical CenterChicago, Illinois
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Coventry Health Care PPO PlatinumCoventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health Freedom
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: